Afuco™ Anti-Human IL19 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-IL19 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibody specific binds to human IL-19, effectively inhibits breast cancer cell proliferation and breast tumor growth, and prolongs survival of mice bearing breast cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-390CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | IL19 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |